---
layout: post
title: "Heritable Intentional Genomic Alterations in Animals: The Approval Process; Guidance for Industry; Availability"
date: 2026-02-04 21:49:32 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2024-31532
original_published: 2025-01-07 00:00:00 +0000
significance: 8.00
---

# Heritable Intentional Genomic Alterations in Animals: The Approval Process; Guidance for Industry; Availability

**Published:** February 04, 2026 21:49 UTC
**Source:** Federal Register
**Original Published:** January 07, 2025 00:00 UTC
**Document Number:** 2024-31532

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry #187B entitled "Heritable Intentional Genomic Alterations in Animals: The Approval Process." This guidance clarifies FDA's requirements and recommendations for developers of intentional genomic alterations (IGAs) in animals. The guidance is one of two companion documents. "Heritable Intentional Genomic Alterations in Animals: The Approval Process" describes how the FDA approval process applies to heritable IGAs in animals. The companion final guidance, GFI #187A entitled "Heritable Intentional Genomic Alterations in Animals: Risk-Based Approach," describes FDA's risk-based regulatory approach to the oversight of heritable IGAs in animals.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/01/07/2024-31532/heritable-intentional-genomic-alterations-in-animals-the-approval-process-guidance-for-industry)
- API: https://www.federalregister.gov/api/v1/documents/2024-31532

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
